ISIN | IE00BKY80X27 |
---|---|
Valor Number | 110728313 |
Bloomberg Global ID | |
Fund Name | New Capital Healthcare Disruptors Fund GBP Acc |
Fund Provider |
EFG - New Capital
EFG Asset Management (UK) Ltd Park House, 116 Park Street London, W1K 6AP, United Kingdom Phone: +44 207 173 8011 E-Mail: enquiries@newcapital.com |
Fund Provider | EFG - New Capital |
Representative in Switzerland |
CACEIS (Switzerland) SA Nyon Phone: +41 22 360 94 00 |
Distributor(s) |
EFG Bank AG Zürich |
Asset Class | Bonds |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Ireland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of the Sub-Fund is to achieve capital appreciation through investment in a portfolio of equity securities. In order to achieve its investment objective, the Sub-Fund will invest in equities issued by US companies listed or traded on Recognised Markets in the United States such as the NASDAQ, the New York Stock Exchange, the American Stock Exchange, the Chicago Mercantile Exchange and the Chicago Board of Trade across all market capitalizations. The Sub-Fund may invest up to a maximum of 20% of the Net Asset Value in non-US companies including up to 10% of its assets in securities of emerging market issuers. |
Peculiarities |
Current Price * | 93.17 GBP | 13.01.2025 |
---|---|---|
Previous Price * | 91.06 GBP | 10.01.2025 |
52 Week High * | 96.08 GBP | 19.09.2024 |
52 Week Low * | 83.05 GBP | 19.04.2024 |
NAV * | 93.17 GBP | 13.01.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 60,561,592 | |
Unit/Share Assets *** | 330,311 | |
Trading Information SIX |
YTD Performance | +4.63% |
31.12.2024 - 13.01.2025
31.12.2024 13.01.2025 |
---|---|---|
YTD Performance (in CHF) | +3.29% |
31.12.2024 - 13.01.2025
31.12.2024 13.01.2025 |
1 month | +0.72% |
13.12.2024 - 13.01.2025
13.12.2024 13.01.2025 |
3 months | -0.11% |
14.10.2024 - 13.01.2025
14.10.2024 13.01.2025 |
6 months | +5.61% |
15.07.2024 - 13.01.2025
15.07.2024 13.01.2025 |
1 year | +9.79% |
16.01.2024 - 13.01.2025
16.01.2024 13.01.2025 |
2 years | +18.40% |
13.01.2023 - 13.01.2025
13.01.2023 13.01.2025 |
3 years | -0.75% |
13.01.2022 - 13.01.2025
13.01.2022 13.01.2025 |
5 years | -6.83% |
18.05.2021 - 13.01.2025
18.05.2021 13.01.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Natera Inc | 5.91% | |
---|---|---|
argenx SE ADR | 5.73% | |
Intuitive Surgical Inc | 4.88% | |
Veracyte Inc | 4.87% | |
Veeva Systems Inc Class A | 4.29% | |
Align Technology Inc | 4.22% | |
Doximity Inc Class A | 4.06% | |
Stryker Corp | 3.97% | |
Ultragenyx Pharmaceutical Inc | 3.77% | |
IDEXX Laboratories Inc | 3.72% | |
Last data update | 31.12.2024 |
TER | 1.0078% |
---|---|
TER date | 30.06.2021 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.75% |
Ongoing Charges *** | 0.99% |
SRRI ***
|
|
SRRI date *** |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |